{"disease":{"id":"unresectable-locally-advanced-invasive-breast-cancer","name":"unresectable locally advanced invasive breast cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02448771","title":"A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}